Jiangsu Hualan New Pharmaceutical Material Co. Ltd.
Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. engages in the research and development, manufacture, and sale of packaging materials for the pharmaceuticals' industry in China and internationally. It offers covered rubber stoppers serise; halogenated butyl rubber stopper freeze-dryied series; halogenated butyl rubber stopper antibiotics series; halogenated butyl rubber plugs infusion series;… Read more
Market Cap & Net Worth: Jiangsu Hualan New Pharmaceutical Material Co. Ltd. (301093)
Jiangsu Hualan New Pharmaceutical Material Co. Ltd. (SHE:301093) has a market capitalization of $1.89 Billion (CN¥13.88 Billion) as of March 18, 2026. Listed on the SHE stock exchange, this China-based company holds position #6414 globally and #975 in its home market, demonstrating a -1.78% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Jiangsu Hualan New Pharmaceutical Material Co. Ltd.'s stock price CN¥84.50 by its total outstanding shares 164201624 (164.20 Million).
Jiangsu Hualan New Pharmaceutical Material Co. Ltd. Market Cap History: 2021 to 2026
Jiangsu Hualan New Pharmaceutical Material Co. Ltd.'s market capitalization history from 2021 to 2026. Data shows growth from $1.10 Billion to $1.89 Billion (13.16% CAGR).
Jiangsu Hualan New Pharmaceutical Material Co. Ltd. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Jiangsu Hualan New Pharmaceutical Material Co. Ltd.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.91x
Jiangsu Hualan New Pharmaceutical Material Co. Ltd.'s market cap is 0.91 times its annual revenue
169.90x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
10.74x
Jiangsu Hualan New Pharmaceutical Material Co. Ltd.'s market cap is 10.74 times its annual earnings
862.31x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $1.10 Billion | $820.87 Million | $216.02 Million | 1.34x | 5.10x |
| 2022 | $546.54 Million | $584.14 Million | $93.75 Million | 0.94x | 5.83x |
| 2023 | $701.19 Million | $622.92 Million | $117.93 Million | 1.13x | 5.95x |
| 2024 | $532.63 Million | $586.41 Million | $49.57 Million | 0.91x | 10.74x |
Competitor Companies of 301093 by Market Capitalization
Companies near Jiangsu Hualan New Pharmaceutical Material Co. Ltd. in the global market cap rankings as of March 18, 2026.
Key companies related to Jiangsu Hualan New Pharmaceutical Material Co. Ltd. by market ranking:
- Intuitive Surgical Inc (NASDAQ:ISRG): Ranked #98 globally with a market cap of $170.40 Billion USD.
- EssilorLuxottica Société anonyme (PINK:ESLOF): Ranked #263 globally with a market cap of $78.22 Billion USD.
- EssilorLuxottica S. A. (PA:EL): Ranked #362 globally with a market cap of $61.18 Billion USD ( €59.61 Billion EUR).
- Becton Dickinson and Company (NYSE:BDX): Ranked #472 globally with a market cap of $45.90 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #98 | Intuitive Surgical Inc | NASDAQ:ISRG | $170.40 Billion | $482.76 |
| #263 | EssilorLuxottica Société anonyme | PINK:ESLOF | $78.22 Billion | $265.00 |
| #362 | EssilorLuxottica S. A. | PA:EL | $61.18 Billion | €203.00 |
| #472 | Becton Dickinson and Company | NYSE:BDX | $45.90 Billion | $161.64 |
Jiangsu Hualan New Pharmaceutical Material Co. Ltd. Historical Marketcap From 2021 to 2026
Between 2021 and today, Jiangsu Hualan New Pharmaceutical Material Co. Ltd.'s market cap moved from $1.10 Billion to $ 1.89 Billion, with a yearly change of 13.16%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥1.89 Billion | +65.36% |
| 2025 | CN¥1.14 Billion | +114.71% |
| 2024 | CN¥532.63 Million | -24.04% |
| 2023 | CN¥701.19 Million | +28.30% |
| 2022 | CN¥546.54 Million | -50.35% |
| 2021 | CN¥1.10 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Jiangsu Hualan New Pharmaceutical Material Co. Ltd. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.89 Billion USD |
| MoneyControl | $1.89 Billion USD |
| MarketWatch | $1.89 Billion USD |
| marketcap.company | $1.89 Billion USD |
| Reuters | $1.89 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.